Bioquell and COVID-19
Learn more about Bioquell and Ecolabs response, our solutions, the latest news, and key information about the COVID-19 pandemic.
In this Clinical Services Journal article, the topic of innovative decontamination efforts and hand hygiene tools are reviewed to show how they have helped hospitals raise infection control standards during the pandemic. Hospitals across the world saw cases rise while also dealing with unique challenges, whether PPE shortages, supply and staff issues, or finding effective […]
Read MoreFDA AUTHORIZES ECOLAB’S BIOQUELL TECHNOLOGY SYSTEM FOR N95 RESPIRATOR DECONTAMINATION Ecolab’s decontamination technology enables respirator reuse by healthcare personnel to help address shortages ST. PAUL, Minn. – December 18, 2020 – Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services that protect people and vital resources, has received Emergency Use […]
Read MoreBioquell Rapid Bio Decontamination Service (RBDS) enables businesses to quickly regain control of clean spaces and ramp up capacity As the world prepares to enter the next phase of the COVID-19 pandemic with the potential relaxation of lockdown restrictions, Bioquell, an Ecolab solution and leading manufacturer of high performance bio-decontamination technology, is utilizing its well-proven […]
Read MoreFollowing the COVID-19 lockdown, environmental monitoring at a major international provider of Biologics Contract Development and Manufacturing Organisations (CDMO) services in Wuhan, China indicated spore contamination in a production room. Despite exhausting all disinfection methods in its records, including the manual application of a sporicide, there was a repeated failure of the EM test standards. […]
Read MoreDuring the COVID-19 pandemic, many hospital wards were temporarily converted to solely treat COVID-19 patients. As these begin to revert back to ‘regular’ non COVID-19 wards, a solution is required to manage the increased potential contamination risk facing the patients admitted to these wards. Our latest case study highlights how Bioquell’s RBDS recently returned an […]
Read More